A curated index of articles, updates, events, and published work across single-cell research.
Nygen at Keystone Symposia Computational Advances in Drug Discovery in London, May 7 to 10, 2026. Short talk by Parashar Dhapola, CEO, on multi-agent AI for evidence-based cell type annotation.
Read more →
Meet Nygen at the Global Innovation Summit 2026 in Basel on May 6. Constance Beyer, Fractional CBO, will be on site for partnering conversations on single-cell analytics and AI for drug discovery.
Read more →
Meet Nygen at Swiss Biotech Day 2026 in Basel on May 4 and 5. Constance Beyer, Fractional CBO, will be on site for partnering conversations on single-cell analytics and AI for drug discovery.
Read more →
Nygen at the 25th BioPharma Drug Discovery Nexus in Zurich, April 29–30, 2026. Session with Parashar Dhapola on AI agents versus AI workflows for single-cell annotation at scale.
Read more →
Meet Nygen at the QIAGEN Agentic AI and Data Innovation Summit in Basel on April 22, 2026. Constance Beyer, Fractional CBO, will be on site for conversations on AI, knowledge graphs, and single-cell data for drug discovery.
Read more →
Nygen Analytics wins 1M SEK Vinnova grant to develop AI-powered predictive models for cancer immunotherapy with VLP Therapeutics, advancing personalized treatment selection.
Read more →
CyteType is multi-agentic annotation system designed for single-cell RNA-seq cluster annotation. Designed to deploy three specialized AI agents to provide accurate cell type identification, literature validation, and pathway-level reasoning beyond traditional marker-based methods and beyond. Built for researchers seeking precise, evidence-backed single-cell data analysis with comprehensive biological context.
Read more →
Nygen Analytics, the only single-cell–focused omics data-analytics platform to pair ISO 27001 certification and SOC 2 compliance with full GDPR alignment
Read more →
Explore how ASI transforms drug discovery by harnessing domain-specific models and advanced computing tools for faster, smarter biomedical innovation.
Read more →